SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-007822
Filing Date
2023-02-03
Accepted
2023-02-03 11:09:18
Documents
14
Period of Report
2023-02-03
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea172695-8k425_viveon.htm   iXBRL 8-K 36385
2 PRESS RELEASE, DATED FEBRUARY 3, 2023 ea172695ex99-1_viveonhealth.htm EX-99.1 3807
  Complete submission text file 0001213900-23-007822.txt   273462

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vhaq-20230203.xsd EX-101.SCH 3914
4 XBRL DEFINITION FILE vhaq-20230203_def.xml EX-101.DEF 27241
5 XBRL LABEL FILE vhaq-20230203_lab.xml EX-101.LAB 37383
6 XBRL PRESENTATION FILE vhaq-20230203_pre.xml EX-101.PRE 25857
8 EXTRACTED XBRL INSTANCE DOCUMENT ea172695-8k425_viveon_htm.xml XML 7092
Mailing Address C/O GIBSON, DEAL, AND FLETCHER, P. C. 3953 NORCROSS GA 30092
Business Address C/O GIBSON, DEAL, AND FLETCHER, P. C. 3953 NORCROSS GA 30092 4045797978
Viveon Health Acquisition Corp. (Filer) CIK: 0001823857 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39827 | Film No.: 23584324
SIC: 2834 Pharmaceutical Preparations